Package 71288-153-95

{"route": ["INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "6b7269e4-757b-4209-b142-d3a2ba369bd4", "openfda": {"nui": ["N0000000233", "N0000175595"], "unii": ["M801H13NRU"], "rxcui": ["485246"], "spl_set_id": ["3b96b508-046b-49ae-aefe-6d39c89a1d0e"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Meitheal Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (71288-153-95)  / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE", "package_ndc": "71288-153-95", "marketing_start_date": "20201102"}], "brand_name": "Azacitidine", "product_id": "71288-153_6b7269e4-757b-4209-b142-d3a2ba369bd4", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "71288-153", "generic_name": "Azacitidine", "labeler_name": "Meitheal Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Azacitidine", "active_ingredients": [{"name": "AZACITIDINE", "strength": "100 mg/1"}], "application_number": "ANDA212128", "marketing_category": "ANDA", "marketing_start_date": "20201102", "listing_expiration_date": "20261231"}